Fungal Diseases in Elasmobranchs and Their Possible Treatment with a Special Mention to Azole Antifungal Agents
Animals · 21.12.2023 · 14 (1) · 43
DOI: 10.3390/ani14010043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Animals, online erschienen am 21.12.2023. Verfasst von Daniela Cañizares-Cooz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, Av. Puerta de Hierro s/n, 28040 Madrid, …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Oceanogràfic.
Abstract (Originalsprache)
Introduction
Elasmobranchs currently constitute an important part of the animal collection of many aquariums worldwide. Their maintenance under human care has allowed us to describe and identify new pathogens and diseases affecting them, as well as to determine different treatments for these diseases. Great advances in elasmobranch husbandry have been developed.
Methods
A search was performed on scientific databases as PubMed and other specialized sources (IAAAM archive).
Results
Little information on pharmacotherapeutics is available in this taxonomic group, and treatments lack a scientific base and instead are frequently dependent on empirical knowledge. Pharmacokinetic studies are the first step to determining therapeutic protocols that are safe and effective. The available bibliography shows that a majority of the mycoses recorded in cartilaginous fish are severe, aggravated by the fact that the antifungal treatments administered, following the guidelines used for teleost species, are ineffective in elasmobranchs. Azoles appear to be a promising group of antifungals for use in treating systemic mycoses in sharks and rays.
Conclusions
Based on the findings of this review, it is essential to investigate the pharmacokinetics of the different antifungals in these species in order to provide therapeutic options for fungal infections in cartilaginous fish.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, Av. Puerta de Hierro s/n, 28040 Madrid, Spain.
- Fundación Oceanogràfic de la Comunitat Valenciana, C/Eduardo Primo Yúfera (Científic) 1B, 46013 Valencia, Spain.
- Veterinary Services, Oceanogràfic, Ciudad de las Artes y las Ciencias, C/Eduardo Primo Yúfera (Científic) 1B, 46013 Valencia, Spain.
ORCID-Profile: Daniel García-Párraga, Carlos Rojo-Solis, Teresa Encinas, Pablo Morón-Elorza
Förderung
- Fundación Oceanogràfic
Zitieren
APA
Cañizares-Cooz, D., García-Párraga, D., Plá-González, E., Rojo-Solis, C., Encinas, T., & Morón-Elorza, P. (2023). Fungal Diseases in Elasmobranchs and Their Possible Treatment with a Special Mention to Azole Antifungal Agents. Animals, 14(1), 43. https://doi.org/10.3390/ani14010043
Vancouver
Cañizares-Cooz D, García-Párraga D, Plá-González E, Rojo-Solis C, Encinas T, Morón-Elorza P. Fungal Diseases in Elasmobranchs and Their Possible Treatment with a Special Mention to Azole Antifungal Agents. Animals. 2023;14(1):43. doi:10.3390/ani14010043
BibTeX
@article{CaizaresCooz2023,
author = {Cañizares-Cooz, Daniela and García-Párraga, Daniel and Plá-González, Emma and Rojo-Solis, Carlos and Encinas, Teresa and Morón-Elorza, Pablo},
title = {Fungal Diseases in Elasmobranchs and Their Possible Treatment with a Special Mention to Azole Antifungal Agents},
journal = {Animals},
year = {2023},
volume = {14},
number = {1},
pages = {43},
doi = {10.3390/ani14010043}
}
EUVIMED